These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

901 related items for PubMed ID: 16788414

  • 1. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 6. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Results of electrocochleography in Ménière's disease after successful vertigo control by single intratympanic gentamicin injection.
    Büki B, Platz M, Haslwanter T, Jünger H, Avan P.
    Audiol Neurootol; 2011 Feb; 16(1):49-54. PubMed ID: 20523039
    [Abstract] [Full Text] [Related]

  • 11. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT, Parnes LS.
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [Abstract] [Full Text] [Related]

  • 12. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 13. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB.
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 15. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 16. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L, Stokroos R, Kingma H.
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [Abstract] [Full Text] [Related]

  • 18. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 19. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 20. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.